ProciseDx Plans Additional Financing in Q1 2020
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read MorePosted by Steve Halasey | Nov 12, 2019 | Allergy & Autoimmune, Point-of-Care |
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read MorePosted by Steve Halasey | Sep 11, 2019 | Blood Gas Analyzers, Controls, Culture Media, Software |
Labs reap the benefits of automated QC and interlaboratory peer-reporting systems.
Read MorePosted by Steve Halasey | Sep 3, 2019 | Point-of-Care, Research |
A study of point-of-care HbA1c testing confirms the benefits of using the Quo-Test analyzer for patients with sight-threatening diabetic retinopathy.
Read MorePosted by Steve Halasey | Aug 7, 2019 | Blood Gas Analyzers, Coagulation Testing, Containers, Controls, Culture Media, Electrolytes, Gastrointestinal Infections, Hematology & Serology, Slides, Software, Standards, Tubes, Water Purification Systems |
Innovative products featured by exhibitors at the American Association for Clinical Chemistry 2019 scientific meeting and clinical lab expo.
Read MorePosted by Chaunie Brusie | Jul 15, 2019 | Culture Media, Library Preparation Systems, Standards |
Clinical laboratories continue to play a vital role when it comes to diabetes diagnosis.
Read More